{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:05:07Z","timestamp":1791356707828,"version":"4.3.1"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.nano.2021.102422","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T04:32:36Z","timestamp":1624595556000},"page":"102422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines"],"prefix":"10.1016","volume":"37","author":[{"given":"Lara","family":"Milane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saket","family":"Dolare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanjheela","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor","family":"Amiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2021.102422_bb0005","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1074\/jbc.RA119.012094","article-title":"The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action","volume":"295","author":"Mitchell","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2021.102422_bb0010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1023\/A:1011991307631","article-title":"DQAsomes: a novel potential drug and gene delivery system made from dequalinium","volume":"15","author":"Weissig","year":"1998","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2021.102422_bb0015","doi-asserted-by":"crossref","first-page":"E277","DOI":"10.1007\/BF02854898","article-title":"Cell-permeable, mitochondrial-targeted, peptide antioxidants","volume":"8","author":"Szeto","year":"2006","journal-title":"AAPS J"},{"key":"10.1016\/j.nano.2021.102422_bb0020","series-title":"Reference module in neuroscience and biobehavioral psychology","author":"DiMauro","year":"2017"},{"key":"10.1016\/j.nano.2021.102422_bb0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2015.03.036","article-title":"Mitochondrial biology, targets, and drug delivery","volume":"207","author":"Milane","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2021.102422_bb0030","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-021-00911-y","article-title":"Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine","author":"Milane","year":"2021","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.nano.2021.102422_bb0035","unstructured":"Carl Zimmer, J. C. a. S.-L. W. Coronavirus vaccine tracker, <https:\/\/www.nytimes.com\/interactive\/2020\/science\/coronavirus-vaccine-tracker.html> (."},{"key":"10.1016\/j.nano.2021.102422_bb0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/1874467212666181127151059","article-title":"Mitochondria-targeted drugs","volume":"12","author":"Zinovkin","year":"2019","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.nano.2021.102422_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188534","article-title":"Mitochondria: The metabolic switch of cellular oncogenic transformation","author":"Tan","year":"2021","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"10.1016\/j.nano.2021.102422_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcdb.2021.02.006","article-title":"Aging: all roads lead to mitochondria","author":"Son","year":"2021","journal-title":"Seminars in Cell & Developmental Biology"},{"key":"10.1016\/j.nano.2021.102422_bb0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mito.2020.12.013","article-title":"The involvement of autophagy in the maintenance of endothelial homeostasis: The role of mitochondria","volume":"57","author":"Dymkowska","year":"2021","journal-title":"Mitochondrion"},{"key":"10.1016\/j.nano.2021.102422_bb0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1053\/sarh.2003.50005","article-title":"Apoptosis: programmed cell death at a molecular level","volume":"32","author":"Schultz","year":"2003","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.nano.2021.102422_bb0065","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.devcel.2020.05.014","article-title":"Endolysosomal targeting of mitochondria is integral to BAX-mediated mitochondrial permeabilization during apoptosis signaling","volume":"53","author":"Wang","year":"2020","journal-title":"Developmental Cell"},{"key":"10.1016\/j.nano.2021.102422_bb0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1083\/jcb.201511036","article-title":"Metabolic regulation of mitochondrial dynamics","volume":"212","author":"Mishra","year":"2016","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nano.2021.102422_bb0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis","volume":"43","author":"Wang","year":"2009","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.nano.2021.102422_bb0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.cdd.4402265","article-title":"Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance","volume":"15","author":"Fadeel","year":"2008","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/j.nano.2021.102422_bb0085","doi-asserted-by":"crossref","first-page":"C111","DOI":"10.1152\/ajpcell.00261.2018","article-title":"Autophagy, apoptosis, and mitochondria: molecular integration and physiological relevance in skeletal muscle","volume":"317","author":"Bloemberg","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.nano.2021.102422_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2020.102308","article-title":"Mitochondria as the decision makers for cancer cell fate: from signaling pathways to therapeutic strategies","volume":"92","author":"Genovese","year":"2020","journal-title":"Cell Calcium"},{"key":"10.1016\/j.nano.2021.102422_bb0095","doi-asserted-by":"crossref","first-page":"330","DOI":"10.18632\/aging.100459","article-title":"Role of apoptosis in disease","volume":"4","author":"Favaloro","year":"2012","journal-title":"Aging"},{"key":"10.1016\/j.nano.2021.102422_bb0100","doi-asserted-by":"crossref","first-page":"10492","DOI":"10.1038\/s41598-017-10673-8","article-title":"Mitochondrial permeability transition pore: sensitivity to opening and mechanistic dependence on substrate availability","volume":"7","author":"Briston","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2021.102422_bb0105","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.bbamcr.2007.10.001","article-title":"Regulation of mitochondrial oxidative phosphorylation through cell signaling","volume":"1773","author":"H\u00fcttemann","year":"2007","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/j.nano.2021.102422_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00302","article-title":"The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death","volume":"4","author":"Bonora","year":"2014","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.nano.2021.102422_bb0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/187152008783961932","article-title":"The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?","volume":"8","author":"L\u00f3pez-L\u00e1zaro","year":"2008","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.nano.2021.102422_bb0120","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1038\/sj.onc.1209603","article-title":"Hexokinase II: cancer\u2019s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria","volume":"25","author":"Mathupala","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.nano.2021.102422_bb0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10863-007-9094-x","article-title":"Warburg, me and hexokinase 2: multiple discoveries of key molecular events underlying one of cancers\u2019 most common phenotypes, the \u201cWarburg effect\u201d, i.e., elevated glycolysis in the presence of oxygen","volume":"39","author":"Pedersen","year":"2007","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.nano.2021.102422_bb0130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.redox.2015.09.005","article-title":"Reactive oxygen species and mitochondria: a nexus of cellular homeostasis","volume":"6","author":"Dan Dunn","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.nano.2021.102422_bb0135","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1074\/jbc.M113.545301","article-title":"The 2-oxoacid dehydrogenase complexes in mitochondria can produce superoxide\/hydrogen peroxide at much higher rates than complex I","volume":"289","author":"Quinlan","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2021.102422_bb0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcdb.2019.05.022","article-title":"Mitochondria as playmakers of apoptosis, autophagy and senescence","volume":"98","author":"Abate","year":"2020","journal-title":"Seminars in Cell & Developmental Biology"},{"key":"10.1016\/j.nano.2021.102422_bb0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.semcdb.2019.05.029","article-title":"Autophagy and mitophagy in cancer metabolic remodelling","volume":"98","author":"Ferro","year":"2020","journal-title":"Seminars in Cell & Developmental Biology"},{"key":"10.1016\/j.nano.2021.102422_bb0150","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/cdd.2009.16","article-title":"Role of BNIP3 and NIX in cell death, autophagy, and mitophagy","volume":"16","author":"Zhang","year":"2009","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/j.nano.2021.102422_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.gde.2017.01.016","article-title":"PINK1\/Parkin mitophagy and neurodegeneration\u2014what do we really know in vivo?","volume":"44","author":"Whitworth","year":"2017","journal-title":"Current Opinion in Genetics & Development"},{"key":"10.1016\/j.nano.2021.102422_bb0160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1083\/jcb.200910140","article-title":"PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy","volume":"189","author":"Matsuda","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nano.2021.102422_bb0165","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/hmg\/ddr048","article-title":"Broad activation of the ubiquitin\u2013proteasome system by Parkin is critical for mitophagy","volume":"20","author":"Chan","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nano.2021.102422_bb0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, Parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.nano.2021.102422_bb0175","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1038\/ncomms3308","article-title":"Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart","volume":"4","author":"Hoshino","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2021.102422_bb0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fcell.2016.00085","article-title":"evolution of per-cell organelle number","volume":"4","author":"Cole","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.nano.2021.102422_bb0185","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nchembio.2102","article-title":"Mitochondrial DNA repair and replication proteins revealed by targeted chemical probes","volume":"12","author":"Wisnovsky","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.nano.2021.102422_bb0190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-genom-091416-035426","article-title":"Recent advances in mitochondrial disease","volume":"18","author":"Craven","year":"2017","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.nano.2021.102422_bb0195","unstructured":"Paupe, V. & Prudent, J. New insights into the role of mitochondrial calcium homeostasis in cell migration. doi:10.17863\/CAM.12394 (2017)."},{"key":"10.1016\/j.nano.2021.102422_bb0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcancer.2008.12.001","article-title":"Mitochondrial dynamics and cancer","volume":"19","author":"Grandemange","year":"2009","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.nano.2021.102422_bb0205","doi-asserted-by":"crossref","unstructured":"Maycotte, P. et al. Mitochondrial dynamics and cancer. Tumor Biology 39, 1010428317698391, doi:https:\/\/doi.org\/10.1177\/1010428317698391 (2017).","DOI":"10.1177\/1010428317698391"},{"key":"10.1016\/j.nano.2021.102422_bb0210","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature20156","article-title":"Correcting mitochondrial fusion by manipulating mitofusin conformations","volume":"540","author":"Franco","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nano.2021.102422_bb0215","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bbamcr.2011.01.021","article-title":"Mitochondrial outer membrane permeabilization during apoptosis: the role of mitochondrial fission","volume":"1813","author":"Landes","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/j.nano.2021.102422_bb0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molcel.2014.10.028","article-title":"Mitochondrial shape governs BAX-induced membrane permeabilization and apoptosis","volume":"57","author":"Renault","year":"2015","journal-title":"Molecular Cell"},{"key":"10.1016\/j.nano.2021.102422_bb0225","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/eci.12135","article-title":"Keeping mitochondria in shape: a matter of life and death","volume":"43","author":"Scorrano","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.nano.2021.102422_bb0230","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41351","article-title":"Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation","volume":"8","author":"Yao","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.nano.2021.102422_bb0235","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2174\/0929867322666150209151851","article-title":"Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance","volume":"22","author":"Gao","year":"2015","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nano.2021.102422_bb0240","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11095-010-0173-z","article-title":"Nanoparticles: a promising modality in the treatment of sarcomas","volume":"28","author":"Susa","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2021.102422_bb0245","doi-asserted-by":"crossref","first-page":"20467","DOI":"10.1038\/srep20467","article-title":"Nanoparticle-mediated targeting of cyclosporine a enhances cardioprotection against ischemia-reperfusion injury through inhibition of mitochondrial permeability transition pore opening","volume":"6","author":"Ikeda","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2021.102422_bb0250","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.nano.2021.102422_bb0255","doi-asserted-by":"crossref","first-page":"20150207","DOI":"10.1259\/bjr.20150207","article-title":"Applications of nanoparticles for diagnosis and therapy of cancer","volume":"88","author":"Baetke","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.nano.2021.102422_bb0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2007.05.040","article-title":"Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria","volume":"121","author":"Horobin","year":"2007","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.nano.2021.102422_bb0265","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejps.2018.04.027","article-title":"Mitochondria-targeting nanomedicine: an effective and potent strategy against aminoglycosides-induced ototoxicity","volume":"126","author":"Zhou","year":"2019","journal-title":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences"},{"key":"10.1016\/j.nano.2021.102422_bb0270","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1007\/s12274-018-2092-y","article-title":"Scavenging of reactive oxygen and nitrogen species with nanomaterials","volume":"11","author":"Ferreira","year":"2018","journal-title":"Nano Res"},{"key":"10.1016\/j.nano.2021.102422_bb0275","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","article-title":"Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications","volume":"117","author":"Zielonka","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.nano.2021.102422_bb0280","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.chembiol.2008.03.015","article-title":"Mitochondria-penetrating peptides","volume":"15","author":"Horton","year":"2008","journal-title":"Chem Biol"},{"key":"10.1016\/j.nano.2021.102422_bb0285","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.2147\/IJN.S163858","article-title":"Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes","volume":"13","author":"Shi","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2021.102422_bb0290","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/mnfr.200700457","article-title":"From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors","volume":"53","author":"Kurtoglu","year":"2009","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.nano.2021.102422_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2012.05.014","article-title":"Targeting drugs to mitochondria","volume":"82","author":"Heller","year":"2012","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.nano.2021.102422_bb0300","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-409X(01)00125-9","article-title":"Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells","volume":"49","author":"Modica-Napolitano","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2021.102422_bb0305","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/s41467-019-09566-3","article-title":"Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2021.102422_bb0310","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrm2959","article-title":"Mitochondrial protein import: from proteomics to functional mechanisms","volume":"11","author":"Schmidt","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.nano.2021.102422_bb0315","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1074\/mcp.M114.043083","article-title":"MitoFates: improved prediction of mitochondrial targeting sequences and their cleavage sites","volume":"14","author":"Fukasawa","year":"2015","journal-title":"Molecular &amp;amp; Cellular Proteomics"},{"key":"10.1016\/j.nano.2021.102422_bb0320","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.chembiol.2008.03.015","article-title":"Mitochondria-penetrating peptides","volume":"15","author":"Horton","year":"2008","journal-title":"Chemistry & Biology"},{"key":"10.1016\/j.nano.2021.102422_bb0325","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1038\/srep03468","article-title":"Dual-targeting pro-apoptotic peptide for programmed cancer cell death via specific mitochondria damage","volume":"3","author":"Chen","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2021.102422_bb0330","author":"Inc., S. B"},{"key":"10.1016\/j.nano.2021.102422_bb0335","author":"Medicine, U. S. N. L. o"},{"key":"10.1016\/j.nano.2021.102422_bb0340","author":"Medicine, U. S. N. L. o"},{"key":"10.1016\/j.nano.2021.102422_bb0345","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jacbts.2018.12.005","article-title":"Elamipretide improves mitochondrial function in the failing human heart","volume":"4","author":"Chatfield","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.nano.2021.102422_bb0350","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrd836","article-title":"New horizons \u2014 alternative routes for insulin therapy","volume":"1","author":"Owens","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2021.102422_bb0355","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/08982100903347931","article-title":"Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol","volume":"20","author":"Patel","year":"2010","journal-title":"J Liposome Res"},{"key":"10.1016\/j.nano.2021.102422_bb0360","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/jps.21939","article-title":"Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations","volume":"99","author":"Migliore","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2021.102422_bb0365","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1007\/s11095-015-1744-9","article-title":"Intranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer\u2019s disease","volume":"32","author":"Zheng","year":"2015","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2021.102422_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2288-8_1","article-title":"DQAsomes as the prototype of mitochondria-targeted pharmaceutical nanocarriers: preparation, characterization, and use","volume":"1265","author":"Weissig","year":"2015","journal-title":"Methods in molecular biology (Clifton, N.J.)"},{"key":"10.1016\/j.nano.2021.102422_bb0375","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.2147\/IJN.S163858","article-title":"Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes","volume":"13","author":"Shi","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2021.102422_bb0380","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn1100","article-title":"Targeting programmed cell death in neurodegenerative diseases","volume":"4","author":"Vila","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.nano.2021.102422_bb0385","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/jpet.112.192138","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"342","author":"Johri","year":"2012","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.nano.2021.102422_bb0390","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrn1477","article-title":"Adult neuron survival strategies \u2014 slamming on the brakes","volume":"5","author":"Benn","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.nano.2021.102422_bb0395","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jns.2018.09.033","article-title":"Mitochondrial therapeutic interventions in Alzheimer\u2019s disease","volume":"395","author":"Van Giau","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nano.2021.102422_bb0400","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","article-title":"Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer\u2019s disease brain is associated with mitochondrial dysfunction","volume":"26","author":"Devi","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.nano.2021.102422_bb0405","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2009.07.005","article-title":"Mitochondrial permeability transition pore in Alzheimer\u2019s disease: cyclophilin D and amyloid beta","volume":"1802","author":"Du","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nano.2021.102422_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2012.08.010","article-title":"Existing and emerging mitochondrial-targeting therapies for altering Parkinson\u2019s disease severity and progression","volume":"137","author":"Pienaar","year":"2013","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.nano.2021.102422_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10010034","article-title":"Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting","volume":"10","author":"Sonvico","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2021.102422_bb0420","doi-asserted-by":"crossref","unstructured":"Chen, Y. & Liu, L. Modern methods for delivery of drugs across the blood\u2013brain barrier. Advanced Drug Delivery Reviews 64, 640\u2013665, doi:https:\/\/doi.org\/10.1016\/j.addr.2011.11.010 (2012).","DOI":"10.1016\/j.addr.2011.11.010"},{"key":"10.1016\/j.nano.2021.102422_bb0425","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1021\/acsnano.5b08045","article-title":"Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer\u2019s disease","volume":"10","author":"Kwon","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2021.102422_bb0430","doi-asserted-by":"crossref","first-page":"16288","DOI":"10.1073\/pnas.1210096109","article-title":"Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics","volume":"109","author":"Marrache","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nano.2021.102422_bb0435","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3389\/fbioe.2019.00447","article-title":"Nanodelivery of natural antioxidants: an anti-aging perspective","volume":"7","author":"Vaiserman","year":"2019","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.nano.2021.102422_bb0440","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1172\/JCI120842","article-title":"The role of mitochondria in aging","volume":"128","author":"Jang","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2021.102422_bb0445","author":"NCI"},{"key":"10.1016\/j.nano.2021.102422_bb0450","author":"NCI"},{"key":"10.1016\/j.nano.2021.102422_bb0455","doi-asserted-by":"crossref","unstructured":"Milane, L. in Nanomedicine for inflammatory diseases (ed Mansoor Amiji and Lara Milane) Ch. Chapter 9, 319\u2013331 (CRC Press, 2017).","DOI":"10.1201\/9781315152356-16"},{"key":"10.1016\/j.nano.2021.102422_bb0460","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.nano.2021.102422_bb0465","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4155\/tde-2018-0062","article-title":"Nanomedicines for cancer therapy: current status, challenges and future prospects","volume":"10","author":"Bor","year":"2019","journal-title":"Ther Deliv"},{"key":"10.1016\/j.nano.2021.102422_bb0470","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.nano.2010.12.009","article-title":"Pharmacokinetics and biodistribution of lonidamine\/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer","volume":"7","author":"Milane","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2021.102422_bb0475","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/mp1002653","article-title":"Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel\/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells","volume":"8","author":"Milane","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2021.102422_bb0480","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2867-11-3","article-title":"Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning","volume":"11","author":"Milane","year":"2011","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.nano.2021.102422_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024075","article-title":"Therapeutic efficacy and safety of paclitaxel\/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer","volume":"6","author":"Milane","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2021.102422_bb0490","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-020-00342-0","article-title":"Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting","volume":"5","author":"Fu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.nano.2021.102422_bb0495","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1021\/acs.molpharmaceut.0c00566","article-title":"Mitochondria-targeted polyamidoamine dendrimer-curcumin construct for hepatocellular cancer treatment","volume":"17","author":"Kianamiri","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2021.102422_bb0500","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.7150\/ijbs.33710","article-title":"Potential mechanisms of action of curcumin for cancer prevention: focus on cellular signaling pathways and miRNAs","volume":"15","author":"Wang","year":"2019","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.nano.2021.102422_bb0505","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/CAD.0000000000000132","article-title":"Curcumin inhibits aerobic glycolysis and induces mitochondrial-mediated apoptosis through hexokinase II in human colorectal cancer cells in vitro","volume":"26","author":"Wang","year":"2015","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.nano.2021.102422_bb0510","doi-asserted-by":"crossref","first-page":"0029","DOI":"10.1038\/s41551-017-0029","article-title":"Designing nanomedicine for immuno-oncology","volume":"1","author":"Jiang","year":"2017","journal-title":"Nature Biomedical Engineering"},{"key":"10.1016\/j.nano.2021.102422_bb0515","series-title":"Nanomedicine for inflammatory diseases","author":"Milane","year":"2017"},{"key":"10.1016\/j.nano.2021.102422_bb0520","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.21873\/anticanres.14498","article-title":"Effects of sclareol against small cell lung carcinoma and the related mechanism: in vitro and in vivo studies","volume":"40","author":"Chen","year":"2020","journal-title":"Anticancer Research"},{"key":"10.1016\/j.nano.2021.102422_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08916930903374741","article-title":"Pathogenic mechanisms in systemic lupus erythematosus","volume":"43","author":"Perl","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.nano.2021.102422_bb0530","first-page":"165845","article-title":"Mitochondrial function in immune cells in health and disease","volume":"2020","author":"Faas","year":"1866","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"10.1016\/j.nano.2021.102422_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2016.05.007","article-title":"The pathogenesis of systemic lupus erythematosus - from the viewpoint of oxidative stress and mitochondrial dysfunction","volume":"30","author":"Lee","year":"2016","journal-title":"Mitochondrion"},{"key":"10.1016\/j.nano.2021.102422_bb0540","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrrheum.2013.147","article-title":"Oxidative stress in the pathology and treatment of systemic lupus erythematosus","volume":"9","author":"Perl","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.nano.2021.102422_bb0545","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrd4477","article-title":"Managing diabetes with nanomedicine: challenges and opportunities","volume":"14","author":"Veiseh","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2021.102422_bb0550","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1211\/jpp.59.4.0004","article-title":"Transport and metabolism of MitoQ10, a mitochondria-targeted antioxidant, in Caco-2 cell monolayers","volume":"59","author":"Li","year":"2007","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nano.2021.102422_bb0555","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1017\/S0007114518001241","article-title":"Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial","volume":"120","author":"Yen","year":"2018","journal-title":"Br J Nutr"},{"key":"10.1016\/j.nano.2021.102422_bb0560","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.redox.2016.12.022","article-title":"The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2\/PINK1","volume":"11","author":"Xiao","year":"2017","journal-title":"Redox Biology"},{"key":"10.1016\/j.nano.2021.102422_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119457","article-title":"Liver-targeted Nano-MitoPBN normalizes glucose metabolism by improving mitochondrial redox balance","volume":"222","author":"Wu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2021.102422_bb0570","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000092847","article-title":"Respiration under control of uncoupling proteins: clinical perspective","volume":"65","author":"N\u00fcbel","year":"2006","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.nano.2021.102422_bb0575","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2337\/diabetes.54.2.322","article-title":"Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity","volume":"54","author":"Ishigaki","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.nano.2021.102422_bb0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224632","article-title":"Mitochondrial dysfunction in rheumatoid arthritis: a comprehensive analysis by integrating gene expression, protein-protein interactions and gene ontology data","volume":"14","author":"Panga","year":"2019","journal-title":"PLOS ONE"},{"key":"10.1016\/j.nano.2021.102422_bb0585","doi-asserted-by":"crossref","DOI":"10.1007\/s40820-020-0410-x","article-title":"ROS-responsive berberine polymeric micelles effectively suppressed the inflammation of rheumatoid arthritis by targeting mitochondria","volume":"12","author":"Fan","year":"2020","journal-title":"Nano-Micro Letters"},{"key":"10.1016\/j.nano.2021.102422_bb0590","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5582\/bst.2016.01122","article-title":"Li, P. & Zhou, D. miR-613 suppresses ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting the programmed cell death 10 gene","volume":"10","author":"Wu","year":"2016","journal-title":"Biosci Trends"},{"key":"10.1016\/j.nano.2021.102422_bb0595","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.2147\/IJN.S250872","article-title":"Nanoparticle-mediated drug delivery for the treatment of cardiovascular diseases","volume":"15","author":"Pala","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2021.102422_bb0600","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003872","volume":"5","author":"Ishikita","year":"2016","journal-title":"J Am Heart Assoc"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:14:23Z","timestamp":1761549263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963421000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":120,"alternative-id":["S1549963421000654"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2021.102422","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2021.102422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102422"}}